Landscapes / Companies
Cara Therapeutics, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials
Trials
0 active
13 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Kappa opioid receptor agonist |
Vifor Fresenius Medical Care Renal Pharma |
Approved | 15 Aug 2029Phase 2 trial completes | ||
| Next date | 15 Aug 2029 · Phase 2 trial completes | ||||
| Also tested for | Pruritus, Chronic Kidney Diseases | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 20 Nov 2026 Industry-sponsored drug trials since 2021